BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Simona Georgescu, Mircea Tampa, Madalina Mitran, Cristina Mitran, Maria Sarbu, Ilinca Nicolae, Clara Matei, Constantin Caruntu, Monica Neagu, Mircea Popa. Potential pathogenic mechanisms involved in the association between lichen planus and hepatitis C virus infection (Review)Experimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.6987
2
Santa Olivera, Angel Perez, Viviana Falcon, Dioslaida Urquiza, Dagmara Pichardo, Gillian Martinez-Donato. Protective cellular immune response against hepatitis C virus elicited by chimeric protein formulations in BALB/c miceArchives of Virology 2020; 165(3): 593 doi: 10.1007/s00705-019-04464-x
3
Muriel Lavie, Xavier Hanoulle, Jean Dubuisson. Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing AntibodiesFrontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.00910
4
Qing Xie, Jian-Wei Xuan, Hong Tang, Xiao-Guang Ye, Peng Xu, I-Heng Lee, Shan-Lian Hu. Hepatitis C virus cure with direct acting antivirals: Clinical, economic, societal and patient value for ChinaWorld Journal of Hepatology 2019; 11(5): 421-441 doi: 10.4254/wjh.v11.i5.421
5
Sina Alizadeh, Shiva Irani, Azam Bolhassani, Seyed Mehdi Sadat. Simultaneous use of natural adjuvants and cell penetrating peptides improves HCV NS3 antigen-specific immune responsesImmunology Letters 2019; 212: 70 doi: 10.1016/j.imlet.2019.06.011
6
Alimuddin Zumla, Martin Rao, Robert S Wallis, Stefan H E Kaufmann, Roxana Rustomjee, Peter Mwaba, Cris Vilaplana, Dorothy Yeboah-Manu, Jeremiah Chakaya, Giuseppe Ippolito, Esam Azhar, Michael Hoelscher, Markus Maeurer. Host-directed therapies for infectious diseases: current status, recent progress, and future prospectsThe Lancet Infectious Diseases 2016; 16(4): e47 doi: 10.1016/S1473-3099(16)00078-5
7
María Q. Marín, Patricia Pérez, Karl Ljungberg, Carlos Óscar S. Sorzano, Carmen E. Gómez, Peter Liljeström, Mariano Esteban, Juan García-Arriaza, J.-H. James Ou. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCVJournal of Virology 2019; 93(7) doi: 10.1128/JVI.00055-19
8
Mohammad Moradi, Farzad Mozafari, Shirin Hosseini, Rouhullah Rafiee, Faezeh Ghasemi. A concise review on impacts of microRNAs in biology and medicine of hepatitis C virusGene Reports 2020; 20: 100761 doi: 10.1016/j.genrep.2020.100761
9
Marianna Zając, Izabela Muszalska, Agnieszka Sobczak, Adrianna Dadej, Szymon Tomczak, Anna Jelińska. Hepatitis C – New drugs and treatment prospectsEuropean Journal of Medicinal Chemistry 2019; 165: 225 doi: 10.1016/j.ejmech.2019.01.025
10
Armina Alagheband Bahrami, Mojgan Bandehpour, Bahram Kazemi, Mahmood Bozorgmehr, Nariman Mosaffa, Rouzbeh Chegeni. Assessment of a poly-epitope candidate vaccine against Hepatitis B, C, and poliovirus in interaction with monocyte-derived dendritic cells: An ex-vivo studyHuman Immunology 2020; 81(5): 218 doi: 10.1016/j.humimm.2020.02.010
11
Cecilia Trucchi, Andrea Orsi, Cristiano Alicino, Laura Sticchi, Giancarlo Icardi, Filippo Ansaldi. State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and ImmunizationJournal of Immunology Research 2016; 2016: 1 doi: 10.1155/2016/1412840
12
Reza Taherkhani, Fatemeh Farshadpour. Global elimination of hepatitis C virus infection: Progresses and the remaining challengesWorld Journal of Hepatology 2017; 9(33): 1239-1252 doi: 10.4254/wjh.v9.i33.1239
13
María Q. Marín, Patricia Pérez, Carmen E. Gómez, Carlos Óscar S. Sorzano, Mariano Esteban, Juan García-Arriaza. Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene ExpressionViruses 2018; 10(8): 414 doi: 10.3390/v10080414
14
Ying Yang, Feng-Ping Wu, Wen-Jun Wang, Juan-Juan Shi, Ya-Ping Li, Xin Zhang, Shuang-Suo Dang. Real life efficacy and safety of direct-acting antiviral therapy for treatment of patients infected with hepatitis C virus genotypes 1, 2 and 3 in northwest ChinaWorld Journal of Gastroenterology 2019; 25(44): 6551-6560 doi: 10.3748/wjg.v25.i44.6551
15
Krupa R. Mysore, Daniel H. Leung. Hepatitis B and CClinics in Liver Disease 2018; 22(4): 703 doi: 10.1016/j.cld.2018.06.002
16
Samaneh Karimkhanilouyi, Saeid Ghorbian. Nucleic acid vaccines for hepatitis B and C virusInfection, Genetics and Evolution 2019; 75: 103968 doi: 10.1016/j.meegid.2019.103968
17
Ashraf Tabll, Reem El-Shenawy, Yasmine El Abd. Update on Hepatitis C2017;  doi: 10.5772/intechopen.70649
18
Amir Atapour, Pooneh Mokarram, Zohreh MostafaviPour, Seyed Younes Hosseini, Younes Ghasemi, Shiva Mohammadi, Navid Nezafat. Designing a Fusion Protein Vaccine Against HCV: An In Silico ApproachInternational Journal of Peptide Research and Therapeutics 2019; 25(3): 861 doi: 10.1007/s10989-018-9735-4
19
Eva Torres-Sangiao, Alina Holban, Monica Gestal. Advanced Nanobiomaterials: Vaccines, Diagnosis and Treatment of Infectious DiseasesMolecules 2016; 21(7): 867 doi: 10.3390/molecules21070867
20
Arthi Venkatesan, Febin Prabhu Dass J.. Review on chemogenomic approaches towards hepatitis C viral targetsJournal of Cellular Biochemistry 2019; 120(8): 12167 doi: 10.1002/jcb.28581
21
Ke-Qin Hu, Wei Cui, Susan D Rouster, Kenneth E Sherman. Hepatitis C virus antigens enzyme immunoassay for one-step diagnosis of hepatitis C virus coinfection in human immunodeficiency virus infected individualsWorld Journal of Hepatology 2019; 11(5): 442-449 doi: 10.4254/wjh.v11.i5.442
22
Zhenqiu Liu, Xianhua Mao, Yanfeng Jiang, Ning Cai, Li Jin, Tiejun Zhang, Xingdong Chen. Changing trends in the disease burden of primary liver cancer caused by specific etiologies in ChinaCancer Medicine 2019; 8(12): 5787 doi: 10.1002/cam4.2477